DR. Mondher Mahjoubi

Dr. Mahjoubi is the Chief Patient Officer of GSK Pharma. He was previously chief executive officer and chairman of the executive board at Innate Pharma. Prior to joining Innate, Dr. Mahjoubi led AstraZeneca’s oncology therapy area franchise, playing an instrumental role in driving its oncology strategy. He also served as the senior vice president of global product strategy at Genentech; before that, he held marketing and medical affairs roles at Roche, Mayne Pharma, Sanofi-Aventis and Rhone Poulenc Rorer. Dr. Mahjoubi is a medical oncologist trained at the Institut Gustave Roussy (Paris-Villejuif). He holds an M.D. from the University of Tunis and certifications in medical oncology from the University of Tunis and University of Paris Sud, as well as in clinical research and methodology from the University of Lariboisiere-Saint Louis.